AzTrials
AzTrials

Brain DeathDONORSNCT03179020

Donation Network to Optimize Organ Recovery Study

A study testing Checklist use in people with Brain Death and Organ Donation, run by Hospital Moinhos de Vento at 63 sites in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study consists in an cluster-randomized clinical trial involving near 60 Brazilian intensive care units (ICUs) with a high notification rate of potential donors of organs and tissues. Read more about this study

Who is it for?
Ages 14 to 90 years
Conditions the study is for
Brain Death, Organ Donation
What is being tested?
Checklist use
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,535 participants
Where
63 sitesBrazil
Study dates
20 Jun 2017to 28 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 90 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • For ICUs:
  • Adults ICUs reporting at least 10 potential valid donors (without clinical contraindications for donation) per year
  • For potential donor:
  • Age of 14 years or older
  • Suspected brain death after the first clinical test

Who cannot join

  • For ICUs:
  • Coronary units, intermediate units, emergency services
  • ICUs that use checklist for the management of the potential donors
  • For potential donors:
  • Age >90 years
  • HIV
Show all 15Show fewer
  • Metastatic cancer
  • Uncontrolled sepsis
  • Acute hepatitis
  • Malaria
  • Acute viral infections
  • Cryptococcal meningoencephalitis and prion diseases
  • Active tuberculosis treated less than 2 months
  • Colonization of the donor by bacteria without any option of antibiotic treatment
  • History of breast tumor, melanoma, soft tissue sarcoma or hematologic neoplasia, WHO Group 3 primary tumors

Trial locations and contacts

63 sites in 1 country.

63 sites in 1 country

Brazil63 sites
  • Hospital de Urgência de Sergipe

    Aracaju, Sergipe

  • Hospital Norte Paranaense

    Arapongas, Paraná

  • Hospital das Clinicas das Minas Gerais

    Belo Horizonte, Minas Gerais

  • Hospital João XXIII Fundação Hospitalar do Estado de Minas Gerais

    Belo Horizonte, Minas Gerais

  • Hospital Universitário Ciências Médicas

    Belo Horizonte, Minas Gerais

  • Santa Casa de Belo Horizonte

    Belo Horizonte, Minas Gerais

  • Hospital das Clínicas de Botucatu

    Botucatu, São Paulo

  • Hospital Universitário São Francisco da Providência de Deus de Bragança Paulista

    Bragança Paulista, São Paulo

  • Hospital de Base do Distrito Federal

    Brasília, Federal District

  • Hospital e Maternidade Angelina Caron

    Campina Grande do Sul, Paraná, 83430-000

  • Santa Casa de Campo Grande

    Campo Grande, Mato Grosso do Sul

  • Hospital Nossa Senhora do Rocio de Campo Largo

    Campo Largo, Paraná

  • Hospital de Canoas

    Canoas, Rio Grande do Sul

  • Hospital Universitário de Cascavel do Oeste do Paraná

    Cascavel, Paraná

  • Hospital Geral Cleriston Andrade

    Feira de Santana, Estado de Bahia

  • Hospital Geral de Fortaleza

    Fortaleza, Ceará

  • Hospital Insituto Dr José Frota

    Fortaleza, Ceará

  • Hospital Municipal Padre Germano Lauk

    Foz do Iguaçu, Paraná, 85864-380

  • Hospital de Urgência de Goiânia

    Goiânia, Goiás

  • Hospital São Vicente de Paulo Guarapuava

    Guarapuava, Paraná

  • Alberto Urquiza Wanderley - Unimed João Pessoa

    João Pessoa, Paraíba

  • Hospital Regional do Cariri

    Juazeiro do Norte, Ceará

  • Hospital Bruno Born

    Lajeado, Rio Grande do Sul

  • Hospital Evangélico de Londrina

    Londrina, Paraná

  • Hospital Universitário Regional do Norte do Paraná

    Londrina, Paraná

  • Hospital Geral Prof. Osvaldo Brandão Vilela

    Maceió, Alagoas

  • Hospital de Pronto Socorro Dr. João Lúcio Pereira Machado

    Manaus, Amazonas

  • Hospital Santa Rita de Maringá

    Maringá, Paraná

  • Hospital Universitário de Maringá

    Maringá, Paraná

  • Irmandade Santa Casa de Misericórdia de Maringá

    Maringá, Paraná

  • Hospital Regional Tarcisio de Vasconcelos Maia

    Mossoró, Ceará

  • Hospital Geral de Nova Iguaçu

    Nova Iguaçu, Rio de Janeiro

  • Hospital São Vicente de Paulo

    Passo Fundo, Rio Grande do Sul

  • Hospital Universitário São Francisco de Paula

    Pelotas, Rio Grande do Sul

  • Hospital de Ensino Doutor Washington Antônio de barros

    Petrolina, Pernambuco

  • Hospital Bom Jesus de Ponta Grossa

    Ponta Grossa, Paraná

  • Hospital Universitario Regional dos Campos Gerais

    Ponta Grossa, Paraná

  • Hospital Cristo Redentor

    Porto Alegre, Rio Grande do Sul

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul

  • Hospital de Pronto Socorro de Porto Alegre

    Porto Alegre, Rio Grande do Sul

  • Irmandade da Santa Casa de Porto Alegre

    Porto Alegre, Rio Grande do Sul

  • Hospital de Pronto Socorro João Paulo II

    Porto Velho, Rondônia

  • Hospital Municipal Irmã Dulce

    Praia Grande, São Paulo

  • Hospital da Restauração

    Recife, Pernambuco

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

    Ribeirão Preto, São Paulo

  • Hospital das Clínicas de Rio Branco

    Rio Branco, Acre

  • Hospital de Urgência e Emergência de Rio Branco

    Rio Branco, Acre

  • Hospital Estadual Getúlio Vargas

    Rio de Janeiro

  • Casa de Saúde de Santos

    Santos, São Paulo

  • Hospital de Base de São José do Rio Preto

    São José do Rio Preto, São Paulo

  • Hospital Dr Carlos Macieira

    São Luís, Maranhão

  • Socorrão I - Hospital Municipal Djalma Marques

    São Luís, Maranhão

  • Hospital Beneficência Portuguesa de São Paulo

    São Paulo

  • Hospital Geral de Taipas

    São Paulo

  • Hospital Paulistano

    São Paulo

  • Hospital São Paulo

    São Paulo

  • Irmandade da Santa Casa de Misericórdia de São Paulo

    São Paulo

  • Hospital Regional Norte

    Sobral, Ceará

  • Santa Casa de Misericórdia de Sobral

    Sobral, Ceará

  • Irmandade Santa Casa de Misericórdia de Sorocaba

    Sorocaba, São Paulo

  • Hospital Regional do Vale do Paraíba

    Taubaté, São Paulo

  • Hospital Bom Jesus de Toledo

    Toledo, Paraná

  • Hospital Estadual de Urgência e Emergência de Vitória

    Vitória, Espírito Santo

Other trials in Brazil

About this study

Official title: Cluster Randomized Trial Evaluating the Implementation of a Evidence Based Checklist for the Management of Potential Organ Donors

This study consists in an cluster-randomized clinical trial involving near 60 Brazilian intensive care units (ICUs) with a high notification rate of potential donors of organs and tissues. ICUs will be randomized in a 1:1 ratio to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care. The primary outcome is the rate of losses of potential donors due to cardiac arrest. Secondary outcome measures include number of effective organ donors and number of organs recovery per effective donor. The first subject was enrolled on June 20, 2018.

Being tested
Checklist use, Usual care
Keywords
Intensive Care Units, Brain Death, Organ Donation, Family interview
Medical subject headings
Brain Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Checklist useOther

    Management of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors.

  • Usual careOther

    Management of the potential donor according usual care.

Study groups in NCT03179020
Study groupRoleWhat they receive
Checklist ICUsExperimentalManagement of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors.
Receives: Other: Checklist use
Usual Care ICUsActive comparatorManagement of the potential donor according usual care.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Losses of potential donors due to cardiac arrest

    Proportion of losses of potential donors due to cardiac arrest

    Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days

Secondary outcomes (2)
  1. Effective organ donor

    Proportion of Effective organ donors

    Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days

  2. Organ recovery per effective donor

    Number of organs recovery per effective donor

    Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery assessed up to 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2017
  2. Study start20 Jun 2017
  3. Primary completion28 Aug 2019
  4. Study completion28 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
In the present study ICUs will be randomized to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care.
Masking
None (open label)
Enrolment
1,535 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03179020
Sponsor's protocol ID
DONORS Study
Acronym
DONORS
Status last verified
Oct 2020
First submitted
23 Mar 2017
Last updated
2 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Publications

  • Westphal GA, Robinson CC, Giordani NE, Teixeira C, Rohden AI, Dos Passos Gimenes B, Guterres CM, Madalena IC, Andrighetto LV, Souza da Silva S, Barbosa da Silva D, Sganzerla D, Cavalcanti AB, Franke CA, Bozza FA, Machado FR, de Andrade J, Pontes Azevedo LC, Schneider S, Orlando BR, Grion CMC, Bezerra FA, Roman FR, Leite FO Jr, Ferraz Siqueira IL, Oliveira JFP, de Oliveira LC Jr, de Melo MFRB, Leal PBGP, Diniz PC, Moraes RB, Salomao Pontes DF, Araujo Queiroz JE, Hammes LS, Meade MO, Rosa RG, Falavigna M; DONORS (Donation Network to Optimize Organ Recovery Study) Investigators and the BRICNet (Brazilian Research in Intensive Care Network). Evidence-Based Checklist to Delay Cardiac Arrest in Brain-Dead Potential Organ Donors: The DONORS Cluster Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2346901. doi: 10.1001/jamanetworkopen.2023.46901.

    PubMed 38095899
  • Giordani NE, Robinson CC, Westphal GA, Rosa RG, Sganzerla D, Cavalcanti AB, Machado FR, Azevedo LCP, Bozza FA, Teixeira C, de Andrade J, Franke CA, Guterres CM, Madalena IC, Rohden AI, da Silva SS, Andrighetto LV, Rech GS, Gimenes BDP, Hammes LS, Pontes DFS, Meade MO, Falavigna M. Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study). Trials. 2020 Jun 17;21(1):540. doi: 10.1186/s13063-020-04457-1.

    PubMed 32552839
  • Westphal GA, Robinson CC, Biasi A, Machado FR, Rosa RG, Teixeira C, de Andrade J, Franke CA, Azevedo LCP, Bozza F, Guterres CM, da Silva DB, Sganzerla D, do Prado DZ, Madalena IC, Rohden AI, da Silva SS, Giordani NE, Andrighetto LV, Benck PS, Roman FR, de Melo MFRB, Pereira TB, Grion CMC, Diniz PC, Oliveira JFP, Mecatti GC, Alves FAC, Moraes RB, Nobre V, Hammes LS, Meade MO, Nothen RR, Falavigna M; DONORS (Donation Network to Optimise Organ Recovery Study) Investigators and the BRICNet. DONORS (Donation Network to Optimise Organ Recovery Study): Study protocol to evaluate the implementation of an evidence-based checklist for brain-dead potential organ donor management in intensive care units, a cluster randomised trial. BMJ Open. 2019 Jun 25;9(6):e028570. doi: 10.1136/bmjopen-2018-028570.

    PubMed 31243035

Questions about this trial

What is this clinical trial studying?

A study testing Checklist use in people with Brain Death and Organ Donation, run by Hospital Moinhos de Vento at 63 sites in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 63 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Losses of potential donors due to cardiac arrest (time frame: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03179020, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in